Skip to main content
. 2020 Nov 3;44(1):164–173. doi: 10.2337/dc20-1842

Figure 4.

Figure 4

Effects of the combination of intensive glycemic control with intensive BP control (ACCORD BP) (A) and fenofibrate (ACCORD Lipid) (B) on CAN risk.